We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$6.97B
AUM Growth
+$4.79B
Cap. Flow
+$6.91B
Cap. Flow %
99.25%
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,370
Increased
1,985
Reduced
143
Closed
794

Top Buys

Rank Stock Value
1
OEF icon
iShares S&P 100 ETF
OEF
+$2.43B
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$1.24B
3
DFAI
Dimensional International Core Equity Market ETF
DFAI
+$202M
4
KORP icon
American Century Diversified Corporate Bond ETF
KORP
+$152M
5
VSS icon
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
+$144M

Top Sells

Rank Stock Value
1
VUG icon
Vanguard Morningstar Growth ETF
VUG
+$91.2M
2
VTV icon
Vanguard Morningstar Value ETF
VTV
+$62.6M
3
AXON
Axon Enterprise
AXON
+$58.1M
4
VO icon
Vanguard Morningstar Mid-Cap ETF
VO
+$46.5M
5
IGSB icon
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 13.48%
2 Financials 8.05%
3 Industrials 7.03%
4 Consumer Discretionary 6.62%
5 Healthcare 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAER icon
3426
Bridger Aerospace
BAER
$103M
$266 ﹤0.01%
+144
New +$273
CRVO icon
3427
CervoMed
CRVO
$25.7M
$258 ﹤0.01%
+32
New +$275
VCEL icon
3428
Vericel Corp
VCEL
$2.34B
$251 ﹤0.01%
8
-17
-68% -$610
BDTX icon
3429
Black Diamond Therapeutics
BDTX
$102M
$250 ﹤0.01%
+66
New +$193
TRUE
3430
DELISTED
TrueCar
TRUE
$247 ﹤0.01%
134
+109
+436% +$219
INO icon
3431
Inovio Pharmaceuticals
INO
$69.4M
$241 ﹤0.01%
+103
New +$197
TECX
3432
Tectonic Therapeutic
TECX
$557M
$235 ﹤0.01%
+15
New +$310
TCI icon
3433
Transcontinental Realty Investors
TCI
$352M
$230 ﹤0.01%
+5
New +$223
NVCT icon
3434
Nuvectis Pharma
NVCT
$618M
$229 ﹤0.01%
+38
New +$261
CXDO icon
3435
Crexendo
CXDO
$216M
$227 ﹤0.01%
+35
New +$217
SNWV
3436
SANUWAVE Health Inc
SNWV
$51.9M
$225 ﹤0.01%
+6
New +$222
INSG icon
3437
Inseego
INSG
$118M
$224 ﹤0.01%
+15
New +$151
GALT icon
3438
Galectin Therapeutics
GALT
$202M
$220 ﹤0.01%
+52
New +$196
DMAC icon
3439
DiaMedica Therapeutics
DMAC
$362M
$219 ﹤0.01%
+32
New +$174
ATLX icon
3440
Atlas Lithium Corp
ATLX
$87.6M
$215 ﹤0.01%
45
-175
-80% -$865
KGEI
3441
Kolibri Global Energy
KGEI
$177M
$211 ﹤0.01%
+38
New +$221
TARA icon
3442
Protara Therapeutics
TARA
$224M
$209 ﹤0.01%
+48
New +$155
TE
3443
T1 Energy
TE
$1.4B
$209 ﹤0.01%
+96
New +$153
INFU icon
3444
InfuSystem Holdings
INFU
$257M
$207 ﹤0.01%
+20
New +$166
RELL icon
3445
Richardson Electronics
RELL
$308M
$205 ﹤0.01%
+21
New +$208
LFT
3446
Lument Finance Trust
LFT
$33.8M
$202 ﹤0.01%
+100
New +$219
AIRE icon
3447
reAlpha
AIRE
$7.89M
$201 ﹤0.01%
+10
New +$128
BITX icon
3448
2x Bitcoin ETF
BITX
$909M
$201 ﹤0.01%
4
-150
-97% -$8.77K
LAZR
3449
CALL
DELISTED
Luminar Technologies
LAZR
$200 ﹤0.01%
+200
New +$491
LCTX icon
3450
Lineage Cell Therapeutics
LCTX
$284M
$199 ﹤0.01%
+118
New +$140
136 137
138
139 140

Similar funds

TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
TH
TCTC Holdings Dallas, Texas $3.51B AUM 30.71% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
WWA
WCG Wealth Advisors Las Vegas, Nevada $3.57B AUM 18.63% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BPS
BNDES Participacoes SA Rio De Janeiro, Brazil $3.58B AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return

Arax Advisory Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,370 new positions and adding to 1,985 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.

  • Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
  • Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
  • Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
  • Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
  • Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
  • Arax Advisory Partners opened 1,370 new positions and closed 794 in Q3 2025.
  • Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.

Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.